Noninvasive determinants of pulmonary hypertension in interstitial lung disease

被引:13
作者
Joseph, Phillip [1 ,5 ]
Savarimuthu, Stella [1 ]
Zhao, Jiayi [2 ]
Yan, Xiting [1 ]
Oakland, Hannah T. [1 ]
Cullinan, Marjorie [3 ]
Heerdt, Paul M. [4 ]
Singh, Inderjit [1 ]
机构
[1] Yale New Haven Hosp, Yale Sch Med, Dept Med, Div Pulm, New Haven, CT 06520 USA
[2] Yale Sch Publ Hlth, Dept Biostat, New Haven, CT USA
[3] Yale New Haven Hosp, Dept Resp Care, New Haven, CT USA
[4] Yale New Haven Hosp, Yale Sch Med, Dept Anaesthesiol, New Haven, CT USA
[5] Yale New Haven Hosp, Yale Sch Med, Dept Med, Div Pulm, New Haven, CT 06511 USA
关键词
cardiopulmonary exercise testing; interstitial lung disease; pulmonary hypertension; NATRIURETIC PEPTIDE LEVELS; INHALED TREPROSTINIL; EXERCISE; VENTILATION; PRESSURE; OBESITY; IMPACT;
D O I
10.1002/pul2.12197
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Pulmonary hypertension (PH) in interstitial lung disease (ILD) is associated with increased mortality and impaired exertional capacity. Right heart catheterization is the diagnostic standard for PH but is invasive and not readily available. Noninvasive physiologic evaluation may predict PH in ILD. Forty-four patients with PH and ILD (PH-ILD) were compared with 22 with ILD alone (non-PH ILD). Six-min walk distance (6MWD, 223 +/- 131 vs. 331 +/- 125 m, p = 0.02) and diffusing capacity for carbon monoxide (DLCO, 33 +/- 14% vs. 55 +/- 21%, p < 0.001) were lower in patients with PH-ILD. PH-ILD patients exhibited a lower gas-exchange derived pulmonary vascular capacitance (GX(CAP), 251 +/- 132 vs. 465 +/- 282 mL x mmHg, p < 0.0001) and extrapolated maximum oxygen uptake (VO2max) (56 +/- 32% vs. 84 +/- 37%, p = 0.003). Multivariate analysis was performed to determine predictors of VO2max. GX(CAP) was the only variable that predicted extrapolated VO2max among PH-ILD and non-PH ILD patients. Receiver operating characteristic curve analysis assessed the ability of individual noninvasive variables to distinguish between PH-ILD and non-PH ILD patients. GX(CAP) (area under the curve [AUC] 0.85 +/- 0.04, p < 0.0001) and delta ETCO2 (AUC 0.84 +/- 0.04, p < 0.0001) were the strongest predictors of PH-ILD. A CART analysis selected GX(CAP), estimated right ventricular systolic pressure (eRVSP) by echocardiogram, and FVC/DLCO ratio as predictive variables for PH-ILD. With this analysis, the AUC improved to 0.94 (sensitivity of 0.86 and sensitivity of 0.93). Patients with a GX(CAP) <= 416 mL x mmHg had an 82% probability of PH-ILD. Patients with GX(CAP) <= 416 mL x mmHg and high FVC/DLCO ratio >1.7 had an 80% probability of PH-ILD. Patients with GX(CAP) <= 416 mL x mmHg and an elevated eRVSP by echocardiogram >43 mmHg had 100% probability of PH-ILD. The incorporation of GX(CAP) with either eRVSP or FVC/DLCO ratio distinguishes between PH-ILD and non-PH-ILD with high probability and may therefore assist in determining the need to proceed with a diagnostic right heart catheterization and potential initiation of pulmonary arterial hypertension-directed therapy in PH-ILD patients.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] Predictors and prognosis of pulmonary hypertension complicating interstitial lung disease in systemic sclerosis
    Morrisroe, Kathleen
    Hansen, Dylan
    Stevens, Wendy
    Ross, Laura
    Sahhar, Joanne
    Ngian, Gene-Siew
    Hill, Catherine
    Host, Lauren
    Walker, Jennifer
    Proudman, Susanna
    Nikpour, Mandana
    RHEUMATOLOGY, 2024,
  • [22] Management of pulmonary hypertension resulting from interstitial lung disease
    Shapiro, S
    CURRENT OPINION IN PULMONARY MEDICINE, 2003, 9 (05) : 426 - 430
  • [23] Interstitial lung disease-associated pulmonary hypertension - what the future holds
    Cottin, Vincent
    Diesler, Remi
    Turquier, Segolene
    Valenzuela, Claudia
    CURRENT OPINION IN PULMONARY MEDICINE, 2023, 29 (05) : 406 - 415
  • [24] Riociguat for interstitial lung disease and pulmonary hypertension: a pilot trial
    Hoeper, Marius M.
    Halank, Michael
    Wilkens, Heinrike
    Guenther, Andreas
    Weimann, Gerrit
    Gebert, Irmingard
    Leuchte, Hanno H.
    Behr, Juergen
    EUROPEAN RESPIRATORY JOURNAL, 2013, 41 (04) : 853 - 860
  • [25] Progress in the Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease
    Nathan, Steven D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 208 (03) : 238 - 246
  • [26] Pulmonary hypertension in interstitial lung disease: screening, diagnosis and treatment
    Behr, Juergen
    Nathan, Steven D.
    CURRENT OPINION IN PULMONARY MEDICINE, 2021, 27 (05) : 396 - 404
  • [27] Pulmonary Hypertension and Lung Transplant in Connective Tissue Disease-Interstitial Lung Disease
    Melendres-Groves, Lana
    Vazquez-Guillamet, Rodrigo
    Dhillon, Gundeep
    CURRENT RESPIRATORY MEDICINE REVIEWS, 2015, 11 (02) : 156 - 162
  • [28] Scleroderma patients with combined pulmonary hypertension and interstitial lung disease
    Chang, B
    Wigley, FM
    White, B
    Wise, RA
    JOURNAL OF RHEUMATOLOGY, 2003, 30 (11) : 2398 - 2405
  • [29] Interstitial Lung Disease and Pulmonary Rehabilitation
    Garvey, Chris
    JOURNAL OF CARDIOPULMONARY REHABILITATION AND PREVENTION, 2010, 30 (03) : 141 - 146
  • [30] Interstitial lung diseases and pulmonary hypertension
    Hauber, H. P.
    INTERNIST, 2009, 50 (09): : 1072 - +